China Pharma Holdings (CPHI) Gross Margin (2010 - 2026)
China Pharma Holdings (CPHI) reported Gross Margin of 29.03% for Q1 2026, up 4100.0% on a YoY basis from 0.69% in Q1 2025, and up 136.02% quarter-over-quarter from 12.3% in Q4 2025.
China Pharma Holdings (CPHI) Gross Margin (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Gross Margin for 17 years, with the latest figure at 29.03% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 4100.0% year-over-year to 29.03%; the trailing twelve-month figure through Mar 2026 stood at 7.26% (up 4990.0% YoY), and the FY2025 full-year result was 3.18%, up 4066.0% from the prior year.
- Gross Margin for Q1 2026 stood at 29.03%, up from 12.3% in the prior quarter.
- The five-year high for Gross Margin was 29.03% in Q1 2026, with the low at 109.78% in Q2 2024.
- Historically, Gross Margin has averaged 13.56% across 5 years, with a median of 10.56% in 2022.
- Annual changes were most pronounced in 2024 — Gross Margin sank 9642 bps — and 2025, when it soared 10130 bps.
- China Pharma Holdings' Gross Margin stood at 1.46% in 2022, then tumbled by 352 bps to 3.68% in 2023, then tumbled by 285 bps to 14.16% in 2024, then surged by 187 bps to 12.3% in 2025, then soared by 136 bps to 29.03% in 2026.
- The last three Gross Margin figures came in at 29.03% (Q1 2026), 12.3% (Q4 2025), and 7.89% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | 29.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.03% |
| Dec 31, 2025 | 12.30% |
| Sep 30, 2025 | -7.89% |
| Jun 30, 2025 | -8.48% |
| Mar 31, 2025 | -11.97% |
| Dec 31, 2024 | -14.16% |
| Sep 30, 2024 | -47.23% |
| Jun 30, 2024 | -109.78% |
| Mar 31, 2024 | -21.17% |
| Dec 31, 2023 | -3.68% |
| Sep 30, 2023 | -12.93% |
| Jun 30, 2023 | -13.36% |
| Mar 31, 2023 | 9.08% |
| Dec 31, 2022 | 1.46% |
| Sep 30, 2022 | -7.01% |
| Jun 30, 2022 | -14.22% |
| Mar 31, 2022 | -10.56% |
| Dec 31, 2021 | 10.45% |
| Sep 30, 2021 | -14.98% |
| Jun 30, 2021 | 2.94% |